X0306 4 2016-02-08 false 0001597553 Sage Therapeutics, Inc. SAGE 0001042021 JONAS JEFFREY M C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 true true false false See Remarks Stock Option (Right to Buy) 28.63 2016-02-08 4 A false 60000.00 0.00 A 2026-02-08 Common Stock 60000.00 60000.00 D The securities awarded on 2/08/2016 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 15,000 shares of common stock shall vest on the one year anniversary of the Vesting Start Date with 45,000 shares vesting in 36 equal monthly installments thereafter. Chief Executive Officer /s/ Erin Lanciani, as Attorney-in-Fact for Jeffrey M. Jonas 2016-02-10